Backed CollimateHealth's oversubscribed EUR6M seed round for microbeam radiation therapy in oncology.
CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated
CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated. This technology delivers an array of extremely narrow, micrometer-scale beams at substantially higher doses, minimizing side effects and enhancing therapeutic delivery.